Your browser doesn't support javascript.
loading
Ancestral origin of ApoE ε4 Alzheimer disease risk in Puerto Rican and African American populations.
Rajabli, Farid; Feliciano, Briseida E; Celis, Katrina; Hamilton-Nelson, Kara L; Whitehead, Patrice L; Adams, Larry D; Bussies, Parker L; Manrique, Clara P; Rodriguez, Alejandra; Rodriguez, Vanessa; Starks, Takiyah; Byfield, Grace E; Sierra Lopez, Carolina B; McCauley, Jacob L; Acosta, Heriberto; Chinea, Angel; Kunkle, Brian W; Reitz, Christiane; Farrer, Lindsay A; Schellenberg, Gerard D; Vardarajan, Badri N; Vance, Jeffery M; Cuccaro, Michael L; Martin, Eden R; Haines, Jonathan L; Byrd, Goldie S; Beecham, Gary W; Pericak-Vance, Margaret A.
Afiliação
  • Rajabli F; John P. Hussman Institute for Human Genomics, Miller School of Medicine, University of Miami, Miami, Florida, United States of America.
  • Feliciano BE; Universidad Central del Caribe, Bayamón, Puerto Rico, United States of America.
  • Celis K; John P. Hussman Institute for Human Genomics, Miller School of Medicine, University of Miami, Miami, Florida, United States of America.
  • Hamilton-Nelson KL; John P. Hussman Institute for Human Genomics, Miller School of Medicine, University of Miami, Miami, Florida, United States of America.
  • Whitehead PL; John P. Hussman Institute for Human Genomics, Miller School of Medicine, University of Miami, Miami, Florida, United States of America.
  • Adams LD; John P. Hussman Institute for Human Genomics, Miller School of Medicine, University of Miami, Miami, Florida, United States of America.
  • Bussies PL; John P. Hussman Institute for Human Genomics, Miller School of Medicine, University of Miami, Miami, Florida, United States of America.
  • Manrique CP; John P. Hussman Institute for Human Genomics, Miller School of Medicine, University of Miami, Miami, Florida, United States of America.
  • Rodriguez A; Universidad Central del Caribe, Bayamón, Puerto Rico, United States of America.
  • Rodriguez V; John P. Hussman Institute for Human Genomics, Miller School of Medicine, University of Miami, Miami, Florida, United States of America.
  • Starks T; Center for Outreach in Alzheimer's, Aging and Community Health at North Carolina A&T State University, Greensboro, North Carolina, United States of America.
  • Byfield GE; Center for Outreach in Alzheimer's, Aging and Community Health at North Carolina A&T State University, Greensboro, North Carolina, United States of America.
  • Sierra Lopez CB; Universidad Central del Caribe, Bayamón, Puerto Rico, United States of America.
  • McCauley JL; John P. Hussman Institute for Human Genomics, Miller School of Medicine, University of Miami, Miami, Florida, United States of America.
  • Acosta H; Clinica de la Memoria, San Juan, Puerto Rico, United States of America.
  • Chinea A; Universidad Central del Caribe, Bayamón, Puerto Rico, United States of America.
  • Kunkle BW; John P. Hussman Institute for Human Genomics, Miller School of Medicine, University of Miami, Miami, Florida, United States of America.
  • Reitz C; Gertrude H. Sergievsky Center, Taub Institute for Research on the Aging Brain, Departments of Neurology, Psychiatry, and Epidemiology, College of Physicians and Surgeons, Columbia University, New York, New York, United States of America.
  • Farrer LA; Departments of Medicine (Biomedical Genetics), Neurology, Ophthalmology, Epidemiology, and Biostatistics, Boston University Schools of Medicine and Public Health, Boston, Massachusetts, United States of America.
  • Schellenberg GD; Penn Neurodegeneration Genomics Center, Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America.
  • Vardarajan BN; Gertrude H. Sergievsky Center, Taub Institute for Research on the Aging Brain, Departments of Neurology, Psychiatry, and Epidemiology, College of Physicians and Surgeons, Columbia University, New York, New York, United States of America.
  • Vance JM; John P. Hussman Institute for Human Genomics, Miller School of Medicine, University of Miami, Miami, Florida, United States of America.
  • Cuccaro ML; Dr. John T. MacDonald Foundation Department of Human Genetics, Miller School of Medicine, University of Miami, Miami, Florida, United States of America.
  • Martin ER; John P. Hussman Institute for Human Genomics, Miller School of Medicine, University of Miami, Miami, Florida, United States of America.
  • Haines JL; Dr. John T. MacDonald Foundation Department of Human Genetics, Miller School of Medicine, University of Miami, Miami, Florida, United States of America.
  • Byrd GS; John P. Hussman Institute for Human Genomics, Miller School of Medicine, University of Miami, Miami, Florida, United States of America.
  • Beecham GW; Dr. John T. MacDonald Foundation Department of Human Genetics, Miller School of Medicine, University of Miami, Miami, Florida, United States of America.
  • Pericak-Vance MA; Department of Population & Quantitative Health Sciences, Institute for Computational Biology, Case Western Reserve University School of Medicine, Cleveland, Ohio, United States of America.
PLoS Genet ; 14(12): e1007791, 2018 12.
Article em En | MEDLINE | ID: mdl-30517106
ABSTRACT
The ApoE ε4 allele is the most significant genetic risk factor for late-onset Alzheimer disease. The risk conferred by ε4, however, differs across populations, with populations of African ancestry showing lower ε4 risk compared to those of European or Asian ancestry. The cause of this heterogeneity in risk effect is currently unknown; it may be due to environmental or cultural factors correlated with ancestry, or it may be due to genetic variation local to the ApoE region that differs among populations. Exploring these hypotheses may lead to novel, population-specific therapeutics and risk predictions. To test these hypotheses, we analyzed ApoE genotypes and genome-wide array data in individuals from African American and Puerto Rican populations. A total of 1,766 African American and 220 Puerto Rican individuals with late-onset Alzheimer disease, and 3,730 African American and 169 Puerto Rican cognitively healthy individuals (> 65 years) participated in the study. We first assessed average ancestry across the genome ("global" ancestry) and then tested it for interaction with ApoE genotypes. Next, we assessed the ancestral background of ApoE alleles ("local" ancestry) and tested if ancestry local to ApoE influenced Alzheimer disease risk while controlling for global ancestry. Measures of global ancestry showed no interaction with ApoE risk (Puerto Rican p-value = 0.49; African American p-value = 0.65). Conversely, ancestry local to the ApoE region showed an interaction with the ApoE ε4 allele in both populations (Puerto Rican p-value = 0.019; African American p-value = 0.005). ApoE ε4 alleles on an African background conferred a lower risk than those with a European ancestral background, regardless of population (Puerto Rican OR = 1.26 on African background, OR = 4.49 on European; African American OR = 2.34 on African background, OR = 3.05 on European background). Factors contributing to the lower risk effect in the ApoE gene ε4 allele are likely due to ancestry-specific genetic factors near ApoE rather than non-genetic ethnic, cultural, and environmental factors.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Negro ou Afro-Americano / Hispânico ou Latino / Apolipoproteína E4 / Doença de Alzheimer Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male País/Região como assunto: Caribe / Puerto rico Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Negro ou Afro-Americano / Hispânico ou Latino / Apolipoproteína E4 / Doença de Alzheimer Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male País/Região como assunto: Caribe / Puerto rico Idioma: En Ano de publicação: 2018 Tipo de documento: Article